The PaceNew therapies / indications available since the last 12 months 
Nilemdo
BY: Julia CheungOct 24, 2023

Nilemdo®
 (bempedoic acid) Daiichi Sankyo

 

Composition:

• Available as film-coated tablet containing 180 mg of bempedoic acid

 

Indication:

• As an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C

You May Be Interested In
Mayzent®
BY: Jasper ChanMar 18, 2022
SkinCeuticals
BY: Julia CheungOct 24, 2023
Lokelma
BY: Olive TseSep 16, 2020
Intrarosa
BY: Olive TseDec 20, 2021